UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 170 filers reported holding UNIQURE NV in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,238 | -62.5% | 21,347 | +12.7% | 0.00% | -100.0% |
| Q1 2023 | $381,532 | -96.4% | 18,944 | -96.7% | 0.00% | -95.5% |
| Q2 2022 | $10,562,000 | +366.9% | 566,645 | +671.3% | 0.02% | +120.0% |
| Q2 2021 | $2,262,000 | -91.1% | 73,466 | -89.5% | 0.01% | -92.7% |
| Q4 2020 | $25,330,000 | -55.3% | 701,084 | -54.4% | 0.14% | -62.2% |
| Q3 2020 | $56,641,000 | +57.1% | 1,537,905 | +92.2% | 0.36% | +43.1% |
| Q2 2020 | $36,046,000 | +4468.6% | 799,977 | +4709.6% | 0.25% | +3062.5% |
| Q1 2020 | $789,000 | -62.0% | 16,633 | -42.6% | 0.01% | -42.9% |
| Q4 2019 | $2,077,000 | -87.0% | 28,994 | -92.9% | 0.01% | -88.9% |
| Q3 2019 | $15,979,000 | +47.1% | 405,968 | +192.1% | 0.13% | +41.6% |
| Q2 2019 | $10,861,000 | +10761.0% | 138,973 | +3917.7% | 0.09% | +8800.0% |
| Q4 2018 | $100,000 | – | 3,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |